Moderna Competitors and Similar CompaniesClear all

Alnylam's competitors and similar companies include .
Alnylam
Alnylam
Alnylam
Alnylam
Alnylam is a biopharmaceutical company that develops ribonucleic acid interference (RNAi) therapeutics for hepatic porphyria, primary hyperoxaluria type 1 (PH1), cardiovascular, and polyneuropathy treatments.
Tags
Tags
Healthcarebiotechpharma
Locations
Locations
Cambridge, US HQ
Paris, FR
Milan, IT
Tokyo, JP
Amsterdam, NL
Stockholm, SE
Zug, CH
see more
Employees
Employees
1,32324% increase
For sources of this data, please see the company profile

View Company Profiles

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Learn more